Technology Meets Purpose: Transforming Clinical Trials with CEO Scott Ogle

Technology Meets Purpose: Transforming Clinical Trials with CEO Scott Ogle

Summary

In this 22nd episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Scott Ogle, CEO of TruTechnologies, discussing his journey from finance to the pharmaceutical industry, the impact of personal experiences on innovation, and the importance of technology in clinical trials. They explore how to hire the best employees in this climate, the significance of company culture, and the influence of family on business perspectives.

Chapters

00:00 Introduction to BioTalk Unzipped

03:15 The Impact of Personal Experience on Innovation

08:47 TruLab's Technology and Its Role in Clinical Trials

14:33 The Importance of Sample Management and the Genesis of TruLab

20:33 NEW NEWS! – The Future of Cancer Treatments

23:34 Hiring Patterns and the value of Company Culture

Takeaways

  • Scott Ogle's personal experience with his father's illness inspired the creation of TruLab.
  • TruLab focuses on eliminating inefficiencies in clinical trial sample management.
  • The importance of having fun in one's career for productivity and happiness.
  • Hiring for energy and cultural fit is crucial for company success.
  • More young people out of college actually prefer working in the office, so it’s a hiring advantage.

Sound Bites

  • “Entrepreneurs get excited about their solution but can forget about what problem they’re solving.”
  • "We need to iterate on technology in clinical trials."
  • “20-25% of biological samples get tossed out.”
  • "You can't coach energy in a candidate."
  • “Company values. Senior leadership must beat it like a drum.”
  • “Interviewing candidates on company values is your North Star.”
  • “Go by what people do, not by what they say.”
  • “Hallway meetings, that’s where stuff gets done.”

New News Story:


How to reach us:

Scott Ogle

https://www.linkedin.com/in/scott-ogle/

TruTechnologies - https://trutechnologies.ai/

Leukemia & Lymphoma Society - https://www.lls.org/

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

ECI - https://eci-rx.com /

Keywords: Scott Ogle, TruLab, clinical trial technology, biotech innovation, sample management in clinical trials, hiring for company culture, company values in leadership, finance to pharma journey, revolutionizing clinical trials, impact of personal experience on innovation, biotechnology leadership, clinical trial inefficiencies, cancer treatment news, digital transformation in pharma, family influence in business, company culture in biotech, pharmaceutical funding challenges, ISB 2001 trispecific T cell engager.

Tags: #ScottOgle, #TruLab, #ClinicalTrials, #Biotech, #PharmaInnovation, #Sample Management, #Company Culture, #Hiring Tips, #BiotechLeadership, #PharmaTechnology, #CancerTreatment, #PersonalInnovation, #BiotechFunding, #LeadershipInPharma, #BusinessLeadership, #PharmaceuticalIndustry.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(45)

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Aug 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Juli 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Juni 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mars 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Dec 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Okt 202531min

Populärt inom Business & ekonomi

framgangspodden
badfluence
varvet
dynastin
rss-borsens-finest
uppgang-och-fall
avanzapodden
svd-tech-brief
rss-inga-dumma-fragor-om-pengar
borsmorgon
fill-or-kill
tabberaset
lastbilspodden
rss-dagen-med-di
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-kort-lang-analyspodden-fran-di
borslunch-2
rss-hos-psykologen
rss-veckans-trade
bathina-en-podcast